Viewing Study NCT03205267


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-01-09 @ 12:42 AM
Study NCT ID: NCT03205267
Status: UNKNOWN
Last Update Posted: 2017-07-02
First Post: 2017-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients
Sponsor: University of Bonn
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module